Osaic Holdings
TEVA icon

Osaic Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Osaic Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.38M Buy
217,692
+136,920
+170% +$4.56M 0.01% 1255
2026
Q1 		$2.43M Sell
80,772
-7,578
-9% -$244K ﹤0.01% 1920
2025
Q4 		$2.76M Buy
88,350
+25,665
+41% +$632K ﹤0.01% 1821
2025
Q3 		$1.18M Buy
62,685
+14,030
+29% +$246K ﹤0.01% 2646
2025
Q2 		$815K Buy
48,655
+7,223
+17% +$117K ﹤0.01% 2687
2025
Q1 		$637K Buy
41,432
+4,202
+11% +$75.1K ﹤0.01% 2647
2024
Q4 		$821K Sell
37,230
-3,839
-9% -$69.8K ﹤0.01% 2360
2024
Q3 		$740K Sell
41,069
-1,066
-3% -$18.7K ﹤0.01% 2511
2024
Q2 		$685K Sell
42,135
-10,247
-20% -$158K ﹤0.01% 2502
2024
Q1 		$739K Sell
52,382
-9,898
-16% -$125K ﹤0.01% 2603
2023
Q4 		$650K Sell
62,280
-46,191
-43% -$431K ﹤0.01% 2931
2023
Q3 		$1.11M Buy
108,471
+24,781
+30% +$231K ﹤0.01% 2549
2023
Q2 		$631K Sell
83,690
-12,206
-13% -$99K ﹤0.01% 2944
2023
Q1 		$851K Sell
95,896
-74,925
-44% -$741K ﹤0.01% 2631
2022
Q4 		$1.56M Sell
170,821
-18,211
-10% -$159K ﹤0.01% 1955
2022
Q3 		$1.53M Buy
189,032
+86,313
+84% +$763K ﹤0.01% 1842
2022
Q2 		$776K Buy
102,719
+5,907
+6% +$51.5K ﹤0.01% 2521
2022
Q1 		$1.08M Sell
96,812
-7,192
-7% -$60K ﹤0.01% 2503
2021
Q4 		$835K Sell
104,004
-16,000
-13% -$144K ﹤0.01% 2570
2021
Q3 		$1.17M Sell
120,004
-56,961
-32% -$533K ﹤0.01% 2204
2021
Q2 		$1.75M Buy
176,965
+34,888
+25% +$369K ﹤0.01% 1834
2021
Q1 		$1.64M Buy
142,077
+18,808
+15% +$216K ﹤0.01% 1787
2020
Q4 		$1.19M Buy
123,269
+3,799
+3% +$36.4K ﹤0.01% 1887
2020
Q3 		$1.09M Buy
119,470
+13,929
+13% +$147K ﹤0.01% 1763
2020
Q2 		$1.3M Sell
105,541
-46,196
-30% -$522K ﹤0.01% 1550
2020
Q1 		$1.34M Buy
+151,737
New +$1.55M 0.01% 1315

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Osaic Holdings's TEVA Position: Q2 2026 in Review

Osaic Holdings increased its Teva Pharmaceuticals (TEVA) stake by 170% in Q2 2026, buying an estimated $4.56M and bringing the position to 217,692 shares worth $7.38M. The position accounts for 0.01% of the portfolio, ranked #1255.

Osaic Holdings first reported a position in TEVA in Q1 2020 and has held it in 26 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Osaic Holdings held 217,692 shares of Teva Pharmaceuticals worth $7.38M as of Q2 2026.
  • Osaic Holdings bought 136,920 Teva Pharmaceuticals shares in Q2 2026, an estimated $4.56M.
  • Teva Pharmaceuticals made up 0.01% of Osaic Holdings's portfolio in Q2 2026, its #1255 holding.
  • Osaic Holdings first reported a position in Teva Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.